Illumina Inc. (Nasdaq: ILMN) lowered its outlook due to reduced demand for its genetic testing services. The stock price tumbled $4.68 to close at $33.46.
Illumina Lowers Outlook
July 02, 2009 at 17:10 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.